Speakers

Richard A. Lewis is head of Computer-aided Drug Design at Novartis in Basel with interests in cheminformatics, ML, protein and structure-based drug design. He earned his B.A. and Ph.D. from Cambridge University, under the supervision of Dr Philip Dean. He performed postdoctoral studies as a Fulbright scholar in the lab of Prof Tack Kuntz at UCSF and as a Royal Commission Fellow in the lab of Prof. Mike Sternberg before joining the team of Jon Mason at RPR in 1991. In 1998 he joined Eli Lilly to lead the European modelling group, and then in 2004 moved to his current role. He has authored over 60 papers and patents, and is a fellow of the Royal Society of Chemistry.

Presentation Title: Advances in Lead Generation - Technologies and Strategies Driving the Discovery of Novel Chemical Entities

View company profile